FAYE M JOHNSON to Platelet-Derived Growth Factor
This is a "connection" page, showing publications FAYE M JOHNSON has written about Platelet-Derived Growth Factor.
Connection Strength
0.126
-
Phase I studies of imatinib mesylate combined with cisplatin and irinotecan in patients with small cell lung carcinoma. Cancer. 2006 Jan 15; 106(2):366-74.
Score: 0.063
-
Induction of heparin-binding EGF-like growth factor and activation of EGF receptor in imatinib mesylate-treated squamous carcinoma cells. J Cell Physiol. 2005 Nov; 205(2):218-27.
Score: 0.063